State production will bring down high costs of insulin

Through state-led manufacturing, CalRx will be the backstop for markets that fail to deliver affordable medications for Californians.

Saved in:
Bibliographic Details
Published inCALmatters
Main Author Ghaly, Mark
Format Newspaper Article
LanguageEnglish
Published Sacramento CALmatters 05.08.2022
Subjects
Cost control
Diabetes
Drug dosages
Employers
Failure
Generic drugs
Insulin
Manufacturing
Pharmacy
Uninsured people
United States > US
California
Online AccessGet full text

Cover

More Information
Summary:Through state-led manufacturing, CalRx will be the backstop for markets that fail to deliver affordable medications for Californians.
Bibliography:ObjectType-News-1
content type line 22
SourceType-Blogs, Podcasts, & Websites-1